title: Application of a tiered approach to the validation of accelerator MS assays.
abstract: Since its introduction into the drug-development arena, accelerator mass spectrometry (coupled with liquid chromatography fractionation) has been used to support a variety of study types. The uses to which the technique has been put include parent and/or metabolite quantification in pharmacokinetic studies, total radioactivity measurement in adsorption, metabolism and excretion studies, and quantitative metabolite profiling. A tiered approach has been applied to the verification of accelerator mass spectrometry assays, dependant on in which type of study and at what stage of drug development they are used. As accelerator mass spectrometry is an absolute detector that can quantify without the use of analyte-related standards, the specific assay verification requirements differ from those for LC-MS/MS assays. This article describes when screening, qualified and validated assay verification procedures should be applied, and suggests what parameters should be assessed in each case.
authors.affiliation: RedX Anti-Infectives Ltd, Biohub, Mereside, Macclesfield, UK.
authors.forename: David
authors.initials: D
authors.lastname: Higton
authors.forename: Mark
authors.initials: M
authors.lastname: Seymour
mesh_terms: D002853:Chromatography, Liquid / Q000379:methods*; D006801:Humans; D013058:Mass Spectrometry / Q000295:instrumentation* / Q000379:methods*; D010315:Particle Accelerators / Q000592:standards*; D053719:Tandem Mass Spectrometry / Q000295:instrumentation* / Q000379:methods*